# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charlotte Brontë (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI025-SYN-TD
- Date: 1855-01-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Eleanor Thwaite, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

One-week review of nausea and vomiting at 8 weeks; maternal-fetal medicine consultation today. **S**

## History of present illness

Ms. Brontë returns one week after starting doxylamine-pyridoxine, two tablets at bedtime, at 8 weeks 1 day. The bedtime dose helps her sleep, but nausea lasts most of the day and she now vomits four or five times a day. She keeps down small amounts of water, tea, and dry crackers most days and passes urine normally. She feels lightheaded only when she gets up quickly. She has stopped writing and lies down most of the afternoon. She has had no pain, bleeding, fever, or diarrhea. Her PUQE-24 score is 11 (moderate), up from 10. She weighs 44.0 kg, 4.3 percent below her pre-pregnancy weight. She saw Dr. Oyelaran-Hughes of maternal-fetal medicine this morning. **S**

| Element | Detail |
|---|---|
| Interval change | Worse: vomiting four or five times a day |
| Intake | Small amounts of fluid and dry food kept down most days |
| Medication | Doxylamine-pyridoxine two tablets at bedtime; no daytime drowsiness |
| PUQE-24 | 11 (moderate), up from 10 |
| Weight | 44.0 kg, 4.3 percent below her pre-pregnancy weight |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; lightheaded only on standing quickly; no fever |
| Gastrointestinal | Positive | Nausea most of the day; vomiting four or five times a day; no pain or diarrhea |
| Genitourinary | Negative | Passing urine normally; no bleeding |
| Psychiatric | Positive | Discouraged but coping; no thoughts of self-harm |

4 systems reviewed. **S**

## Current medications

- Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe) **S**
- Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, one tablet in the morning, one mid-afternoon, and two at bedtime (four a day) **S**
- Metoclopramide 10 mg oral tablet, one tablet by mouth three times a day before meals **S**

## Allergies

- No known allergy **S**

## Objective

BP 102/64 mmHg; pulse 92 bpm; respirations 14/min; temperature 36.8 °C; oxygen saturation 99% on room air; weight 44 kg; BMI 19 kg/m². All vital signs are synthetic.

Sodium: 136 mmol/L; Potassium: 3.6 mmol/L; Chloride: 99 mmol/L; Bicarbonate (total CO2): 26 mmol/L; BUN: 11 mg/dL; Creatinine: 0.58 mg/dL; Glucose: 74 mg/dL; Urine ketones: 40 mg/dL (high). All results are synthetic.

## Change since baseline

- Sodium: 137 mmol/L at baseline, 136 mmol/L at this visit **S**
- Potassium: 3.9 mmol/L at baseline, 3.6 mmol/L at this visit **S**
- Chloride: 102 mmol/L at baseline, 99 mmol/L at this visit **S**
- Bicarbonate (total CO2): 24 mmol/L at baseline, 26 mmol/L at this visit **S**
- BUN: 8 mg/dL at baseline, 11 mg/dL at this visit **S**
- Creatinine: 0.52 mg/dL at baseline, 0.58 mg/dL at this visit **S**
- Glucose: 76 mg/dL at baseline, 74 mg/dL at this visit **S**
- Urine ketones: 15 mg/dL (high) at baseline, 40 mg/dL (high) at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Slight and tired; not distressed |
| Hydration | Mucous membranes slightly dry; no orthostatic drop in blood pressure; pulse 92 |
| Neck | Thyroid not enlarged |
| Abdomen | Soft and non-tender |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Nausea and vomiting of pregnancy, moderate and worsening** (O21.9). PUQE-24 score 11 with 4.3 percent weight loss. Sodium 136, potassium 3.6, chloride 99, bicarbonate 26 mmol/L, urea nitrogen 11, creatinine 0.58, and glucose 74 mg/dL are normal, with potassium at the low end. Urine ketones 40 mg/dL are recorded but do not measure dehydration. She still keeps fluids down, so she does not yet meet the definition of hyperemesis gravidarum, but she is close to it. **S**
   - Raise doxylamine-pyridoxine to four tablets a day: one in the morning, one mid-afternoon, and two at bedtime.
   - Add metoclopramide 10 mg three times a day before meals, as Dr. Oyelaran-Hughes advised; stop it and call if restlessness or abnormal movements develop.
   - Ondansetron discussed, including the very small absolute increase in orofacial clefting with first-trimester use; she prefers to keep it in reserve and will accept it if these steps fail.
   - Same-day review if she cannot keep fluids down for 24 hours, feels faint, passes little urine, or loses more than 5 percent of her pre-pregnancy weight (below 43.7 kg).
2. **First pregnancy at 38** (O09.519). Intake results: blood group O, RhD positive, antibody screen negative; rubella immune; hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests negative; urine culture no growth; interferon-gamma release assay negative, so there is no latent tuberculosis infection and no chest radiograph is needed. Hemoglobin 12.8 g/dL. She would like cell-free DNA screening from 10 weeks and a nuchal translucency scan at 11 to 14 weeks, and does not want diagnostic testing unless a screen is positive. **S**
   - Cell-free DNA screening at the next visit.
   - Nuchal translucency scan at 12 to 13 weeks.
   - Low-dose aspirin assessment at 12 weeks: two moderate risk factors.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PUQE-24 score (recorded in the note; no LOINC code found) | Every visit while nausea and vomiting last | Completed today | 11 (moderate), up from 10 |
| Examination | Weight against pre-pregnancy weight (46.0 kg), pulse, blood pressure, and hydration | Every visit while nausea and vomiting last | Completed today | 44.0 kg, down 4.3 percent; pulse 92; no orthostatic drop; mucous membranes slightly dry |
| Laboratory | Electrolytes, urea nitrogen, creatinine, and glucose | When vomiting is moderate or severe, daily while on intravenous fluids, and until stable on oral intake | Completed today | Normal; potassium 3.6 mmol/L at the low end |
| Laboratory | Urine ketones | With vomiting; recorded but not a measure of severity or dehydration | Completed today | 40 mg/dL |
| Laboratory | TSH and free T4 | In hyperemesis gravidarum; repeat at 16 to 18 weeks if suppressed | Not indicated | Not yet needed: no hyperemesis; to be checked if it develops |
| Medication safety | Antiemetic effects: drowsiness with doxylamine-pyridoxine; restlessness and abnormal movements with metoclopramide | Every visit and after each change | Completed today | No daytime drowsiness; metoclopramide starts today with counseling to stop it if restlessness or abnormal movements occur |
| Laboratory | First prenatal tests (blood group, antibody screen, rubella, hepatitis B, HIV, syphilis, hepatitis C, urine culture) | At the first prenatal visit | Completed today | Reviewed today: all normal or negative |
| Laboratory | Interferon-gamma release assay for tuberculosis | Once, for household tuberculosis exposure | Completed today | Negative; reviewed with her |
| Referral | Maternal-fetal medicine consultation | Early in a first pregnancy at 38 with worsening nausea and vomiting | Completed today | Seen today; escalation thresholds, screening, and aspirin plan agreed |
| Survey | Aneuploidy screening choice | Offered before 10 weeks | Completed today | Chose cell-free DNA from 10 weeks with a nuchal translucency scan; declined diagnostic testing unless a screen is positive |
| Examination | Blood pressure | Every prenatal visit | Completed today | 102/64 mmHg |
| Examination | Fetal heart | Every prenatal visit once audible by handheld Doppler (from about 10 to 12 weeks) | Not indicated | Not yet reliably audible by Doppler at 8 weeks; cardiac activity was seen on the dating scan a week ago |

## Goal progress

- Nausea and vomiting mild (PUQE-24 score 6 or less) and weight back to her pre-pregnancy 46.0 kg by about 17 weeks. In progress; target 1855-03-24. **S**
- Hydration and electrolytes normal within two weeks of any admission. In progress; target 1855-02-10. **S**
- An informed choice about aneuploidy screening and diagnostic testing by 13 weeks. In progress; target 1855-02-24. **S**
- Low-dose aspirin started between 12 and 16 weeks if indicated. In progress; target 1855-02-24. **S**
- Tuberculosis screening completed and explained by the second visit. Outcome by 1855-01-20: Interferon-gamma release assay negative; no latent infection; no chest radiograph needed. **S**
- Mood screened in each trimester, with support offered. In progress; target 1855-03-24. **S**

## Medication changes

- Stopped: Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, two tablets by mouth at bedtime **S**
- Started: Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, one tablet in the morning, one mid-afternoon, and two at bedtime (four a day) **S**
- Started: Metoclopramide 10 mg oral tablet, one tablet by mouth three times a day before meals **S**

## Guideline basis

- ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024), Royal College of Obstetricians and Gynaecologists (BJOG)
- Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Latent Tuberculosis Infection in Adults: Screening (2023), U.S. Preventive Services Task Force

## Follow-up

- Review in about three weeks, at 11 weeks, sooner by telephone or same day if the thresholds are reached. **S**
- Next scheduled visit 1855-02-10: prenatal visit at 11 weeks: nausea and vomiting review and cell-free DNA screening. **S**
